{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:30:14Z","timestamp":1715531414398},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"vor","delay-in-days":9742,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1993]]},"DOI":"10.1254\/jjp.63.399","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T05:09:52Z","timestamp":1201151392000},"page":"399-404","source":"Crossref","is-referenced-by-count":11,"title":["Effects of OPC-18790, a New Positive Inotropic Agent, on Canine Ventricular Arrhythmias"],"prefix":"10.1016","volume":"63","author":[{"given":"Wu","family":"Zhenjiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Awaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humiaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.63.399_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF01744451","article-title":"Cardiovascular actions of OPC-18790: A novel positive inotropic agent with little chronotropic action","volume":"7","author":"Hosokawa","year":"1992","journal-title":"Heart Vessels"},{"key":"10.1254\/jjp.63.399_bib2","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1021\/jm00098a003","article-title":"Novel positive inotropic agents: Synthesis and biological activities of 6-(3-amino-2-hydroxypropoxy)-2(lH)-quinolinone derivatives","volume":"35","author":"Fujioka","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1254\/jjp.63.399_bib3","first-page":"347","article-title":"Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart","volume":"34","author":"Taira","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"10.1254\/jjp.63.399_bib4","first-page":"342","article-title":"In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), a novel positive inotropic drug, in various animals","volume":"34","author":"Yamashita","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"10.1254\/jjp.63.399_bib5","first-page":"390","article-title":"Positive inotropic effect of 3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(l\/7)-quinolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure","volume":"34","author":"Hashimoto","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"10.1254\/jjp.63.399_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1476-5381.1986.tb16266.x","article-title":"Effects of OPC-8212, a new positive inotropic agent, on canine ventricular arrhythmias","volume":"88","author":"Hashimoto","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1254\/jjp.63.399_bib7","first-page":"445","article-title":"Effects of milrinone on canine experimental arrhythmias","volume":"7","author":"Hashimoto","year":"1990","journal-title":"Coronary"},{"key":"10.1254\/jjp.63.399_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1254\/jjp.50.421","article-title":"The first demonstration of CGRP-immunoreactive fibers in canine hearts: Coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated, blood-perfused heart preparations","volume":"50","author":"Sugiyama","year":"1989","journal-title":"Japan. J. Pharmacol."},{"key":"10.1254\/jjp.63.399_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1254\/jjp.53.97","article-title":"Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog","volume":"53","author":"Sugiyama","year":"1990","journal-title":"Japan. J. Pharmacol."},{"key":"10.1254\/jjp.63.399_bib10","first-page":"801","article-title":"Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia","volume":"223","author":"Hashimoto","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1254\/jjp.63.399_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02066484","article-title":"Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: A comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN1 165","volume":"1","author":"Hashimoto","year":"1985","journal-title":"Heart Vessels"},{"key":"10.1254\/jjp.63.399_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00005344-198307000-00005","article-title":"Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dogs","volume":"5","author":"Shibuya","year":"1983","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1254\/jjp.63.399_bib13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/BF00120829","article-title":"Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: Which electrophysiological characteristics of drugs are related to their effectiveness?","volume":"5","author":"Hashimoto","year":"1991","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1254\/jjp.63.399_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.RES.41.4.415","article-title":"Action potentials, afterpotentials, and arrhythmias","volume":"41","author":"Cranefield","year":"1977","journal-title":"Circ. Res."},{"key":"10.1254\/jjp.63.399_bib15","series-title":"The Heart and Cardiovascular System","first-page":"2113","article-title":"Afterdepolarizations and triggered activity: Distinction from automaticity as an arrhythmogenic mechanism","author":"Wit","year":"1992"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819359438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819359438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T23:51:34Z","timestamp":1605657094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819359438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993]]}},"alternative-id":["S0021519819359438"],"URL":"https:\/\/doi.org\/10.1254\/jjp.63.399","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1993]]}}}